Clearmind Medicine share price logo

Clearmind Medicine

NASDAQ: CMND

$5.87

-0.13

(-2.17%)

as on

Clearmind Medicine Stock Performance

as on October 24, 2026 at 2:16 pm IST

  • Day's High

    $5.87
    $6.25

    6.47%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.25
    $3,840.00
    downward going graph

    10.56%

    Downside

    65317.38%

    Upside

    downward going graph

Clearmind Medicine share price movements today

Previous Close
$6.00
Open
$6.25
Volume
186.6K
Market Cap
$3.0M
Day's Low - High
$5.87 - $6.25
52 Week Low - High
$5.25 - $3,840.00

Clearmind Medicine Historical Returns

1 Month Return
-11.76 %
3 Month Return
-54.82 %
1 Year Return
-99.81 %
3 Year Return
-99.96 %
5 Year Return
0 %

Clearmind Medicine Stock Fundamentals & Key Indicators

Check Clearmind Medicine market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0M

EPS (TTM)

-89.2

Dividend Yield

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-3.14

PEG Ratio

0.00

Return On Equity TTM

-87.29%

Clearmind Medicine vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clearmind Medicine with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$3.0MNA-0.070.00%0.00%
Neutral$80.9B-38.72%-25.39-12.57%0.00%
StrongBuy$43.5BNA26.4687.82%0.00%
StrongBuy$135.6B185.49%30.9086.04%0.00%
Buy$83.1B40.65%19.5684.86%0.46%

Stock Returns calculator for Clearmind Medicine Stock including INR - Dollar returns

The Clearmind Medicine stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Clearmind Medicine investment value today

Current value as on today

₹202

Returns

-₹99,798

(-99.8%)

Returns from Clearmind Medicine Stock

-₹99,813 (-99.81%)

Dollar Impact

₹15 (+0.02%)

Indian Investors' Interest in Clearmind Medicine Stock

Search interest for Clearmind Medicine Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Clearmind Medicine Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-1
-1
-1
-1
-1
-3
-1
-2
EBITDA
0
-2
-1
-1
0
-1
0
-3
-1
-2
Interest Expense
-
-
0
0
0
0
-
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-2
0
-1
0
-1
0
-3
-2
0
Income Tax Expense
0
0
0
0
0
0
-
0
0
0
Net Income
0
-2
0
-1
0
-1
0
-3
-2
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Clearmind Medicine Annual Profit & Loss

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Jan 2021
Jan 2022
Jan 2023
Oct 2023
Oct 2024
Oct 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
0
0
0
0
0
Operating Income
0
-
0
0
-3
-9
-6
-5
-5
EBITDA
0
0
0
0
-
-9
-8
-4
-3
Interest Expense
-
-
-
-
-
0
-
0
0
Depreciation
-
-
-
-
-
0
0
0
0
Income Before Tax
0
0
0
0
-3
-9
-8
-4
-3
Income Tax Expense
-
-
-
-
-
0
0
0
0
Net Income
0
0
0
0
-3
-9
-8
-5
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Clearmind Medicine Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
-1
-2
-1
-1
-1
-1
0
-3
-2
0
Operating Cash Flow
-1
-1
-1
-1
-1
-1
-1
-2
-1
-1
Investing Cash Flow
0
0
0
0
0
0
0
-
0
0
Financing Cash Flow
0
0
0
0
0
0
3
7
4
3
Change in Cash
-1
0
-1
0
-1
0
0
5
2
0

Clearmind Medicine Annual Cash Flow

All numbers in Millions USD

Oct 2017
Oct 2018
Oct 2019
Jan 2021
Jan 2022
Jan 2023
Oct 2023
Oct 2024
Oct 2025
Net Income
0
0
0
0
-2
-9
-8
-7
-3
Operating Cash Flow
0
0
0
0
-2
-5
-6
-6
-4
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
-
0
5
0
11
8
2
Change in Cash
0
0
0
0
3
-4
5
1
-2

Global Institutional Holdings in Clearmind Medicine

Check out the Institutions with significant holdings in Clearmind Medicine.

Funds
Holdings
AdvisorShares
0.03%

Clearmind Medicine News & Key Events

  • img

    Today's Timeline - 23 September

    Wed, 06:16 PM

    -

    NeuroThera Labs expands U.S. IP portfolio with three patent applications for novel drug combinations targeting mental health and substance use disorders.

Insights on Clearmind Medicine

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 150.9% return, outperforming this stock by 250.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 648.3% return, outperforming this stock by 748.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CMND stock has moved down by -54.4%

About Clearmind Medicine

Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.
OrganisationClearmind Medicine
Headquarters1220 West 6th Avenue, Vancouver, BC, V6H 1A5, CA
IndustryBiotechnology
CEOAdi Zuloff-Shani

Key Management of Clearmind Medicine

Name

Title

Dr. Adi Zuloff-Shani Ph.D.

Chief Executive Officer

Mr. Alan Mark Rootenberg B.Com., B.Comm, C.A., C.P.A.

Chief Financial Officer

Prof. Mark Haden M.S.W.

Vice President of Business Development

Ms. Mylene Touboul

Accounting Manager

Ms. Mary-Elizabeth Gifford

Chief of Global Impact

Ms. Adi Varon

Controller

FAQs

What is Clearmind Medicine share price today?

Clearmind Medicine share price today is $5.87 as on at the close of the market. Clearmind Medicine share today touched a day high of $6.25 and a low of $5.87.

What is the 52 week high and 52 week low for Clearmind Medicine share?

Clearmind Medicine share touched a 52 week high of $3,840.00 on and a 52 week low of $5.25 on . Clearmind Medicine stock price today i.e. is closed at $5.87,which is 99.85% down from its 52 week high and 11.81% up from its 52 week low.

What is Clearmind Medicine's market capitalisation today?

Clearmind Medicine market capitalisation is $0.00T as on .

How to invest in Clearmind Medicine Stock (CMND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Clearmind Medicine on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Clearmind Medicine Stock (CMND) from India?

Indian investors can start investing in Clearmind Medicine (CMND) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Clearmind Medicine stock (as per the Rupee-Dollar exchange rate as on ). Based on Clearmind Medicine share’s latest price of $5.87 as on October 24, 2026 at 8:46 am IST, you will get 1.7036 shares of Clearmind Medicine. Learn more about fractional shares .